ArticleOncotarget2016

Correction: Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src.

Marco Perez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.